Table 1.
Clinico-pathological characteristics of the adenocarcinoma patients in Yale cohorts A and B.
| Yale Cohort A | Yale Cohort B | |||
|---|---|---|---|---|
| n=125 | n=98 | |||
|
| ||||
| Age | (44–91 years) | (42–84 years) | ||
|
| ||||
| <70 years | 73 | 58.4% | 59 | 60.2% |
| ≥70 years | 52 | 41.6% | 39 | 39.8% |
|
| ||||
| Sex | ||||
|
| ||||
| Male | 42 | 33.6% | 42 | 42.9% |
| Female | 83 | 66.4% | 56 | 57.1% |
|
| ||||
| Stage at Diagnosis | ||||
|
| ||||
| 0/I | 80 | 64.0% | 54 | 55.1% |
| II | 26 | 20.8% | 10 | 10.2% |
| III | 14 | 11.2% | 26 | 26.5% |
| IV | 5 | 4.0% | 8 | 8.2% |
|
| ||||
| Smoking History | ||||
|
| ||||
| Non-Smoker | 24 | 19.2% | 12 | 12.2% |
| Former/Current Smoker | 95 | 70.0% | 83 | 84.7% |
| Unknown | 6 | 4.8% | 3 | 3.1% |